This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 12, 2024, with a ceiling value of $10,618.77 and a completion date of December 13, 2024. The contract is a Firm Fixed Price Delivery Order, and there was no set-aside used.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award is likely a delivery order under that broader IDC, enabling efficient government procurement of essential pharmaceutical products to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 3/13/25, 9:44 AM